Atricure Stock Today
| ATRC Stock | USD 23.17 0.46 2.03% |
Performance0 of 100
| Odds Of DistressLess than 9
|
AtriCure is trading at 23.17 as of the 24th of April 2024, a 2.03 percent up since the beginning of the trading day. The stock's open price was 22.71. AtriCure has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AtriCure are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of January 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 5th of August 2005 | Category Healthcare | Classification Health Care |
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. The company has 48.37 M outstanding shares of which 3.25 M shares are presently shorted by private and institutional investors with about 4.03 trading days to cover. More on AtriCure
Moving together with AtriCure Stock
| 0.72 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | FONR | Fonar | PairCorr |
Moving against AtriCure Stock
| 0.65 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
| 0.52 | STIM | Neuronetics Financial Report 14th of May 2024 | PairCorr |
| 0.42 | AGTI | Agiliti Sell-off Trend | PairCorr |
AtriCure Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AtriCure's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AtriCure or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Michael Carrel | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering AtriCure report their recommendations after researching AtriCure's financial statements, talking to executives and customers, or listening in on AtriCure's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering AtriCure. The AtriCure consensus assessment is calculated by taking the average forecast from all of the analysts covering AtriCure. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from AtriCure's historical financial statements, AtriCure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of AtriCure is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AtriCure's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to AtriCure's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AtriCure's financial leverage. It provides some insight into what part of AtriCure's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AtriCure (ATRC) is traded on NASDAQ Exchange in USA. It is located in 7555 Innovation Way, Mason, OH, United States, 45040 and employs 1,200 people. AtriCure is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AtriCure's market, we take the total number of its shares issued and multiply it by AtriCure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AtriCure conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 48.37 M outstanding shares of which 3.25 M shares are presently shorted by private and institutional investors with about 4.03 trading days to cover.
AtriCure currently holds about 118.45 M in cash with 4.42 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.55.
Check AtriCure Probability Of Bankruptcy
Ownership AllocationAtriCure retains a total of 48.37 Million outstanding shares. The majority of AtriCure outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AtriCure to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AtriCure. Please pay attention to any change in the institutional holdings of AtriCure as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check AtriCure Ownership Details
AtriCure Stock Price Odds Analysis
What are AtriCure's target price odds to finish over the current price? Based on a normal probability distribution, the odds of AtriCure jumping above the current price in 90 days from now is about 98.0%. The AtriCure probability density function shows the probability of AtriCure stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.1605. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, AtriCure will likely underperform. Additionally, atriCure has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of AtriCure to move above the current price in 90 days from now is about 98.0 (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 90 days) .
AtriCure Stock Institutional Holders
Institutional Holdings refers to the ownership stake in AtriCure that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AtriCure's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AtriCure's value.| Instituion | Recorded On | Shares | |
| Nuveen Asset Management, Llc | 2023-12-31 | 1 M | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 1 M | |
| Credit Suisse First Boston (csfb) | 2023-12-31 | 990.4 K | |
| Timessquare Capital Management, Llc | 2023-12-31 | 976.1 K | |
| Fiera Capital Corporation | 2023-12-31 | 881.8 K | |
| Hood River Capital Management Llc | 2023-12-31 | 841.1 K | |
| Loomis, Sayles & Company Lp | 2023-12-31 | 834.1 K | |
| Bellevue Group Ag | 2023-12-31 | 817.9 K | |
| Gw&k Investment Management, Llc | 2023-12-31 | 805.1 K | |
| Vanguard Group Inc | 2023-12-31 | 4.8 M | |
| Blackrock Inc | 2023-12-31 | 4.2 M |
AtriCure Historical Income Statement
AtriCure Income Statement is one of the three primary financial statements used for reporting AtriCure's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AtriCure revenue and expense. AtriCure Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, AtriCure's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 312.3 M, whereas Operating Income is projected to grow to (29.5 M). View More FundamentalsAtriCure Stock Against Markets
Picking the right benchmark for AtriCure stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AtriCure stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AtriCure is critical whether you are bullish or bearish towards AtriCure at a given time. Please also check how AtriCure's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AtriCure without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
AtriCure Corporate Directors
AtriCure corporate directors refer to members of an AtriCure board of directors. The board of directors generally takes responsibility for the AtriCure's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AtriCure's board members must vote for the resolution. The AtriCure board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Regina Groves | Independent Director | Profile | |
| Scott Drake | Independent Director | Profile | |
| Mark Collar | Independent Director | Profile | |
| Mark Lanning | Independent Director | Profile |
How to buy AtriCure Stock?
Before investing in AtriCure, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AtriCure. To buy AtriCure stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of AtriCure. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase AtriCure stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located AtriCure stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased AtriCure stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AtriCure, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy AtriCure Stock please use our How to Invest in AtriCure guide.
Already Invested in AtriCure?
The danger of trading AtriCure is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AtriCure is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AtriCure. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AtriCure is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share 8.621 | Quarterly Revenue Growth 0.21 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.